tiprankstipranks
Trending News
More News >
Pascal Biosciences Inc (TSE:NEVI)
:NEVI
Canadian Market
Advertisement

Pascal Biosciences Inc (NEVI) Ratios

Compare
5 Followers

Pascal Biosciences Inc Ratios

TSE:NEVI's free cash flow for Q1 2025 was C$0.78. For the 2025 fiscal year, TSE:NEVI's free cash flow was decreased by C$ and operating cash flow was C$0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.87 0.79 0.02 0.22 0.20
Quick Ratio
0.42 0.57 0.02 0.22 0.20
Cash Ratio
0.07 0.37 <0.01 0.00 0.00
Solvency Ratio
>-0.01 -0.26 -0.49 -1.66 -2.59
Operating Cash Flow Ratio
0.02 -0.34 -0.17 -0.95 -1.82
Short-Term Operating Cash Flow Coverage
0.03 -0.56 -0.66 -79.25 -51.03
Net Current Asset Value
C$ -103.92KC$ -237.43KC$ -944.11KC$ -501.28KC$ -378.65K
Leverage Ratios
Debt-to-Assets Ratio
0.23 0.27 11.93 0.05 0.14
Debt-to-Equity Ratio
0.36 0.50 -0.24 -0.02 -0.05
Debt-to-Capital Ratio
0.27 0.33 -0.31 -0.02 -0.05
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.60 1.81 -0.02 -0.32 -0.34
Debt Service Coverage Ratio
0.10 -0.39 -2.08 -79.96 -51.68
Interest Coverage Ratio
-2.89 0.00 0.00 -193.56 -190.34
Debt to Market Cap
0.18 0.36 0.17 <0.01 <0.01
Interest Debt Per Share
0.01 0.03 0.02 <0.01 <0.01
Net Debt to EBITDA
8.34 -0.99 -0.46 >-0.01 -0.01
Profitability Margins
Gross Profit Margin
61.78%58.51%0.00%0.00%0.00%
EBIT Margin
-13.10%-56.36%0.00%0.00%0.00%
EBITDA Margin
3.15%-39.75%0.00%0.00%0.00%
Operating Profit Margin
-7.30%-129.27%0.00%0.00%0.00%
Pretax Profit Margin
-16.33%-59.53%0.00%0.00%0.00%
Net Profit Margin
-16.33%-59.53%0.00%0.00%0.00%
Continuous Operations Profit Margin
-16.33%-59.53%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
223.77%46.05%86.24%100.73%97.42%
Return on Assets (ROA)
-12.52%-16.02%-2551.56%-701.69%-1025.50%
Return on Equity (ROE)
-20.50%-29.05%50.87%221.65%351.35%
Return on Capital Employed (ROCE)
-8.97%-63.07%66.90%220.04%360.66%
Return on Invested Capital (ROIC)
-6.58%-42.15%91.63%223.57%378.84%
Return on Tangible Assets
-37.29%-44.35%-2551.56%-701.69%-1025.50%
Earnings Yield
-10.05%-21.24%-36.64%-20.18%-13.97%
Efficiency Ratios
Receivables Turnover
6.96 3.25 0.00 0.00 0.00
Payables Turnover
0.00 0.86 0.05 0.05 0.04
Inventory Turnover
1.75 1.12 0.00 0.00 0.00
Fixed Asset Turnover
77.60 33.88 0.00 0.00 0.00
Asset Turnover
0.77 0.27 0.00 0.00 0.00
Working Capital Turnover Ratio
-56.88 -1.26 0.00 0.00 0.00
Cash Conversion Cycle
260.45 14.56 -6.73K -7.94K -9.55K
Days of Sales Outstanding
52.47 112.42 0.00 0.00 0.00
Days of Inventory Outstanding
207.99 325.26 0.00 0.00 0.00
Days of Payables Outstanding
0.00 423.12 6.73K 7.94K 9.55K
Operating Cycle
260.45 437.68 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 -0.02 -0.01 -0.05 -0.08
Free Cash Flow Per Share
<0.01 -0.02 -0.01 -0.05 -0.08
CapEx Per Share
<0.01 <0.01 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.86 1.01 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
1.16 -74.93 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
1.16 -74.93 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
0.03 -0.56 -0.66 -79.25 -51.03
Operating Cash Flow to Sales Ratio
<0.01 -0.57 0.00 0.00 0.00
Free Cash Flow Yield
1.05%-20.75%-11.27%-11.40%-9.73%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-9.95 -4.71 -2.73 -4.96 -7.16
Price-to-Sales (P/S) Ratio
1.63 2.80 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
2.00 1.37 -1.39 -10.98 -25.16
Price-to-Free Cash Flow (P/FCF) Ratio
95.62 -4.82 -8.88 -8.78 -10.27
Price-to-Operating Cash Flow Ratio
177.71 -4.88 -8.88 -8.78 -10.27
Price-to-Earnings Growth (PEG) Ratio
-0.35 0.09 0.05 0.23 0.11
Price-to-Fair Value
2.00 1.37 -1.39 -10.98 -25.16
Enterprise Value Multiple
59.95 -8.04 -3.26 -5.06 -7.29
Enterprise Value
2.99M 2.15M 1.53M 5.40M 8.88M
EV to EBITDA
59.95 -8.04 -3.26 -5.06 -7.29
EV to Sales
1.89 3.20 0.00 0.00 0.00
EV to Free Cash Flow
111.07 -5.50 -10.34 -8.79 -10.29
EV to Operating Cash Flow
206.42 -5.57 -10.34 -8.79 -10.29
Tangible Book Value Per Share
>-0.01 >-0.01 -0.07 -0.04 -0.03
Shareholders’ Equity Per Share
0.03 0.06 -0.07 -0.04 -0.03
Tax and Other Ratios
Effective Tax Rate
<0.01 0.00 <0.01 <0.01 >-0.01
Revenue Per Share
0.04 0.03 0.00 0.00 0.00
Net Income Per Share
>-0.01 -0.02 -0.04 -0.09 -0.11
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.25 1.06 1.01 1.01 1.01
Research & Development to Revenue
0.00 0.05 0.00 0.00 0.00
SG&A to Revenue
0.49 1.41 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.61 0.00 0.00 0.00
Income Quality
-0.06 0.96 0.31 0.56 0.70
Currency in CAD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis